AltrX™ was built on the proven clinical heritage of Marathon® cross-linked polyethylene. Introduced in 1998, Marathon was the first FDA-cleared cross-linked polyethylene in orthopaedics.
Dislocation is the most common postoperative complication in total hip reconstruction. In revision hip surgery, dislocation rates have been reported as high as 25 percent. The Duraloc® Constrained Liner is indicated for use in total hip cases where dislocation represents a significant postoperative concern.